Glycogen synthase kinase-3β inhibition reduces secondary damage in experimental spinal cord trauma

Salvatore Cuzzocrea, Tiziana Genovese, Emanuela Mazzon, Concetta Crisafulli, Rosanna Di Paola, Carmelo Muià, Marika Collin, Emanuela Esposito, Placido Bramanti, Christoph Thiemermann

Research output: Contribution to journalArticle

Abstract

Glycogen synthase kinase-3 (GSK-3) has recently been identified as an ubiquitous serine-threonine protein kinase that participates in a multitude of cellular processes and plays an important role in the pathophysiology of a number of diseases. The aim of this study was to investigate the effects of GSK-3β inhibition on the degree of experimental spinal cord trauma induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. Spinal cord injury (SCI) in mice resulted in severe trauma characterized by edema, neutrophil infiltration, production of a range of inflammatory mediators, tissue damage, and apoptosis. Treatment of the mice with 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8), a potent and selective GSK-3β inhibitor, significantly reduced the degree of 1) spinal cord inflammation and tissue injury (histological score); 2) neutrophil infiltration (myeloperoxidase activity); 3) inducible nitric-oxide synthase, nitrotyrosine, and cyclooxygenase-2 expression; and 4) and apoptosis (terminal deoxynucleotidyl transferase dUTP nick-end labeling staining and Bax and Bcl-2 expression). In a separate set of experiments, TDZD-8 significantly ameliorated the recovery of limb function (evaluated by motor recovery score). Taken together, our results clearly demonstrate that treatment with TDZD-8 reduces the development of inflammation and tissue injury associated with spinal cord trauma.

Original languageEnglish
Pages (from-to)79-89
Number of pages11
JournalJournal of Pharmacology and Experimental Therapeutics
Volume318
Issue number1
DOIs
Publication statusPublished - 2006

Fingerprint

Glycogen Synthase Kinase 3
Spinal Cord Injuries
Neutrophil Infiltration
Wounds and Injuries
Apoptosis
Myelitis
Laminectomy
DNA Nucleotidylexotransferase
Protein-Serine-Threonine Kinases
Recovery of Function
Nitric Oxide Synthase Type II
Cyclooxygenase 2
Surgical Instruments
Peroxidase
Blood Vessels
Edema
Extremities
Staining and Labeling
Inflammation
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione

ASJC Scopus subject areas

  • Pharmacology

Cite this

Glycogen synthase kinase-3β inhibition reduces secondary damage in experimental spinal cord trauma. / Cuzzocrea, Salvatore; Genovese, Tiziana; Mazzon, Emanuela; Crisafulli, Concetta; Di Paola, Rosanna; Muià, Carmelo; Collin, Marika; Esposito, Emanuela; Bramanti, Placido; Thiemermann, Christoph.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 318, No. 1, 2006, p. 79-89.

Research output: Contribution to journalArticle

Cuzzocrea, S, Genovese, T, Mazzon, E, Crisafulli, C, Di Paola, R, Muià, C, Collin, M, Esposito, E, Bramanti, P & Thiemermann, C 2006, 'Glycogen synthase kinase-3β inhibition reduces secondary damage in experimental spinal cord trauma', Journal of Pharmacology and Experimental Therapeutics, vol. 318, no. 1, pp. 79-89. https://doi.org/10.1124/jpet.106.102863
Cuzzocrea, Salvatore ; Genovese, Tiziana ; Mazzon, Emanuela ; Crisafulli, Concetta ; Di Paola, Rosanna ; Muià, Carmelo ; Collin, Marika ; Esposito, Emanuela ; Bramanti, Placido ; Thiemermann, Christoph. / Glycogen synthase kinase-3β inhibition reduces secondary damage in experimental spinal cord trauma. In: Journal of Pharmacology and Experimental Therapeutics. 2006 ; Vol. 318, No. 1. pp. 79-89.
@article{91b65e01c49f43d3ba1159c0336aef09,
title = "Glycogen synthase kinase-3β inhibition reduces secondary damage in experimental spinal cord trauma",
abstract = "Glycogen synthase kinase-3 (GSK-3) has recently been identified as an ubiquitous serine-threonine protein kinase that participates in a multitude of cellular processes and plays an important role in the pathophysiology of a number of diseases. The aim of this study was to investigate the effects of GSK-3β inhibition on the degree of experimental spinal cord trauma induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. Spinal cord injury (SCI) in mice resulted in severe trauma characterized by edema, neutrophil infiltration, production of a range of inflammatory mediators, tissue damage, and apoptosis. Treatment of the mice with 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8), a potent and selective GSK-3β inhibitor, significantly reduced the degree of 1) spinal cord inflammation and tissue injury (histological score); 2) neutrophil infiltration (myeloperoxidase activity); 3) inducible nitric-oxide synthase, nitrotyrosine, and cyclooxygenase-2 expression; and 4) and apoptosis (terminal deoxynucleotidyl transferase dUTP nick-end labeling staining and Bax and Bcl-2 expression). In a separate set of experiments, TDZD-8 significantly ameliorated the recovery of limb function (evaluated by motor recovery score). Taken together, our results clearly demonstrate that treatment with TDZD-8 reduces the development of inflammation and tissue injury associated with spinal cord trauma.",
author = "Salvatore Cuzzocrea and Tiziana Genovese and Emanuela Mazzon and Concetta Crisafulli and {Di Paola}, Rosanna and Carmelo Mui{\`a} and Marika Collin and Emanuela Esposito and Placido Bramanti and Christoph Thiemermann",
year = "2006",
doi = "10.1124/jpet.106.102863",
language = "English",
volume = "318",
pages = "79--89",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Glycogen synthase kinase-3β inhibition reduces secondary damage in experimental spinal cord trauma

AU - Cuzzocrea, Salvatore

AU - Genovese, Tiziana

AU - Mazzon, Emanuela

AU - Crisafulli, Concetta

AU - Di Paola, Rosanna

AU - Muià, Carmelo

AU - Collin, Marika

AU - Esposito, Emanuela

AU - Bramanti, Placido

AU - Thiemermann, Christoph

PY - 2006

Y1 - 2006

N2 - Glycogen synthase kinase-3 (GSK-3) has recently been identified as an ubiquitous serine-threonine protein kinase that participates in a multitude of cellular processes and plays an important role in the pathophysiology of a number of diseases. The aim of this study was to investigate the effects of GSK-3β inhibition on the degree of experimental spinal cord trauma induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. Spinal cord injury (SCI) in mice resulted in severe trauma characterized by edema, neutrophil infiltration, production of a range of inflammatory mediators, tissue damage, and apoptosis. Treatment of the mice with 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8), a potent and selective GSK-3β inhibitor, significantly reduced the degree of 1) spinal cord inflammation and tissue injury (histological score); 2) neutrophil infiltration (myeloperoxidase activity); 3) inducible nitric-oxide synthase, nitrotyrosine, and cyclooxygenase-2 expression; and 4) and apoptosis (terminal deoxynucleotidyl transferase dUTP nick-end labeling staining and Bax and Bcl-2 expression). In a separate set of experiments, TDZD-8 significantly ameliorated the recovery of limb function (evaluated by motor recovery score). Taken together, our results clearly demonstrate that treatment with TDZD-8 reduces the development of inflammation and tissue injury associated with spinal cord trauma.

AB - Glycogen synthase kinase-3 (GSK-3) has recently been identified as an ubiquitous serine-threonine protein kinase that participates in a multitude of cellular processes and plays an important role in the pathophysiology of a number of diseases. The aim of this study was to investigate the effects of GSK-3β inhibition on the degree of experimental spinal cord trauma induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. Spinal cord injury (SCI) in mice resulted in severe trauma characterized by edema, neutrophil infiltration, production of a range of inflammatory mediators, tissue damage, and apoptosis. Treatment of the mice with 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8), a potent and selective GSK-3β inhibitor, significantly reduced the degree of 1) spinal cord inflammation and tissue injury (histological score); 2) neutrophil infiltration (myeloperoxidase activity); 3) inducible nitric-oxide synthase, nitrotyrosine, and cyclooxygenase-2 expression; and 4) and apoptosis (terminal deoxynucleotidyl transferase dUTP nick-end labeling staining and Bax and Bcl-2 expression). In a separate set of experiments, TDZD-8 significantly ameliorated the recovery of limb function (evaluated by motor recovery score). Taken together, our results clearly demonstrate that treatment with TDZD-8 reduces the development of inflammation and tissue injury associated with spinal cord trauma.

UR - http://www.scopus.com/inward/record.url?scp=33745241901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745241901&partnerID=8YFLogxK

U2 - 10.1124/jpet.106.102863

DO - 10.1124/jpet.106.102863

M3 - Article

C2 - 16601144

AN - SCOPUS:33745241901

VL - 318

SP - 79

EP - 89

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -